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a b s t r a c t
Myasthenia gravis (MG), the most common autoimmune disease of neuromuscular junction (NMJ), is
heterogeneous in terms of pathophysiology, which is determined by the pathogenic antigen of
autoantibodies targeting to synaptic proteins at the NMJs. Currently, patients suspected with MG are
routinely screened for the presence of autoantibodies against acetylcholine receptor (AChR) or muscle-
speciﬁc kinase (MuSK) using a cell-based assay (CBA) that involves the expression of target synaptic
membrane protein in heterologous cell lines. However, some autoantibodies may only show reactivity
for binding to densely clustered AChR in the physiological conformation, while AChR clustering is known
to involve signaling events orchestrated by over a dozen of postsynaptic proteins. To improve the
existing serological diagnosis of MG, this study explored the possibility of using the well-established
Xenopus primary culture system as a novel CBA for MG. Here, by examining the pathogenic effects of four
MG human plasma samples, we found that the samples from both seropositive and seronegative MG
patients effectively induced the disassembly of aneural AChR clusters in cultured Xenopus muscle cells,
as well as the nerve-induced AChR clusters in the nerve–muscle co-cultures. Importantly, the
disassembly of AChR clusters was spatio-temporally correlated to the disappearance of actin depoly-
merizing factor (ADF)/coﬁlin, an actin regulator involved in AChR trafﬁcking and clustering. Taken
together, this study develops a reliable CBA using Xenopus primary cultures for screening the
pathogenicity of human MG plasma samples, and providing a platform for investigating the pathogenic
mechanisms underlying the endocytic trafﬁcking and degradation of AChRs at NMJs in MG patients.
& 2015 Elsevier Inc. All rights reserved.
Introduction
At the neuromuscular junction (NMJ), the postsynaptic mem-
brane in skeletal muscles contains a very high density of acet-
ylcholine receptor (AChR) molecules to make the
neurotransmission between motor neurons and muscle ﬁbers
more efﬁcient. Myasthenia gravis (MG) is a prototypical
antibody-mediated autoimmune disease that is characterized by
the weakness of the skeletal muscle contraction, ranging from
minor eyelid movement problems to serious breathing defects.
About 85% of MG patients have anti-AChR antibodies in their
serum (seropositive MG, SPMG), which recognize a complex array
of epitopes that varies between each individual patient
(Lindstrom, 2000). Therefore, the epitope recognized by the anti-
AChR antibody determines its pathogenic potential. The patho-
genic antibody binds to the extracellular domains of AChR on the
postsynaptic membrane that are accessible for the crosslinking of
nearby AChR molecules (Beroukhim and Unwin, 1995). However,
recent studies showed that the remaining 15% of MG patients that
are negative to the presence of anti-AChR antibodies (identiﬁed
initially as seronegative MG, SNMG) may also contain pathogenic
antibodies against other postsynaptic proteins, namely muscle-
speciﬁc receptor tyrosine kinase (MuSK), low-density lipoprotein
receptor-related protein 4 (Lrp4), or agrin (Higuchi et al., 2011;
Hoch et al., 2001; Zhang et al., 2014). Currently, a tremendous
amount of research has been devoted to identifying the novel
targets for autoantibodies in patients initially classiﬁed as SNMG.
The antibody-mediated crosslinking of AChR molecules, or
possibly other postsynaptic membrane proteins, increases their
internalization and degradation rates (termed antigenic modula-
tion), thus contributing to the reduced density of AChR clusters at
the NMJs in MG patients. In addition, the effects of autoantibodies
binding to a small fraction of AChRs are greatly ampliﬁed by the
assembly of membrane attack complex, which attracts phagocytes
in mediating a complement-dependent cytotoxic response at the
endplates (termed complement-mediated cell lysis). This causes
the destructive changes in the junctional folds of postsynaptic
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membrane resulting in the shedding of AChR-enriched membrane
fragments into the synaptic space (Mendell et al., 1996). Although
both antigenic modulation and complement-mediated cell lysis
are involved in MG pathogenesis, the stabilization of AChR by
rapsyn over-expression is able to prevent AChR loss in the
experimental animal MG rats, even in the presence of the
activated complement (Losen et al., 2005; Mendell et al., 1996).
Hence, this suggested that the prevention of antigenic modulation
may represent a possible therapy for MG.
At present, the most common CBA for MG requires the transfection
of the target auto-antigens in the heterologous cell lines
(Zisimopoulou et al., 2013). The transfected cells are then incubated
with diluted MG patient serum, and the presence of bound patient
autoantibodies on the cells is detected by immunocytochemical
analysis. However, this assay can only demonstrate the binding of
autoantibodies to the exogenously expressed postsynaptic proteins in
heterologous cells, but not the endocytosis of clustered AChR mole-
cules that are endogenously expressed in skeletal muscle ﬁbers.
Moreover, recent studies showed that some autoantibodies in MG
patients can only bind to and react with the densely clustered AChRs
in the physiological conformation (Devic et al., 2014; Jacob et al., 2012),
which could not be reproduced in heterologous cell lines with the
expression of one or a few postsynaptic proteins. With these limita-
tions, this study therefore aims to develop a novel CBA using Xenopus
tissue cultures to validate the pathogenicity of autoantibodies in MG
patient plasma on the disassembly of AChR clusters.
Xenopus tissue cultures have long been used as the model system
for studying the NMJ development in vitro (Anderson and Cohen,
1977; Kuromi and Kidokoro, 1984; Peng et al., 1991). In the absence of
nerve innervation, AChRs are expressed in cultured Xenopus muscle
cells, and are spontaneously aggregated to form the pre-existing
clusters, also known as hotspots or aneural clusters (Lee et al., 2009;
Rochlin and Peng, 1990). Intriguingly, these morphologically complex
aneural AChR clusters can also be found in a mouse muscle cell line,
inwhich they undergo a similar topological transformation mirroring
the observations during synaptic maturation of NMJs in vivo
(Kummer et al., 2004). In Xenopus nerve–muscle co-cultures, the
formation of NMJs can easily be followed upon the physical contact
between the spinal neurons and muscle cells by visualizing the
dynamic redistribution of AChR molecules from the aneural clusters
to the nascent synaptic sites (Anderson and Cohen, 1977; Lee et al.,
2009). Importantly, cDNAs encoding α, γ, and δ subunits of the
Xenopus AChR have been shown to share a high amino acid sequence
homology to their Torpedo homologs (Baldwin et al., 1988). The
expression of ε subunit is delayed with respect to that of γ subunit
during development in Xenopus embryos, consistent with the transi-
tion in the subunit composition of the AChR from embryonic to adult
properties in the mammalian NMJs (Missias et al., 1996; Reuer et al.,
1994). Taken together, the use of aneural and synaptic AChR clusters
that are endogenously expressed and assembled in the physiological
conformation in Xenopus tissue cultures serves as a reliable assay for
screening the pathogenicity of MG human patient plasma samples.
Since the endocytosis of cross-linked AChRs is likely the rate-limiting
step to the antigenic modulation in vitro and in vivo (Lindstrom and
Einarson, 1979), this CBA can also be employed to elucidate the
pathogenic mechanisms underlying the internalization and degrada-
tion of AChRs and other postsynaptic proteins during the pathogen-
esis of MG.
Materials and methods
Xenopus embryo microinjection and primary cell culture preparation
A DNA construct encoding the green ﬂuorescent protein (GFP)-
tagged Xenopus ADF/coﬁlin (XAC) was micro-injected into one
blastomere of 2-cell stage Xenopus embryos using an oocyte
injector, Nanoject (Drummond Scientiﬁc) as described previously
(Lee et al., 2009; Lee et al., 2014). Typically, each embryo was
injected with 20–100 pg of DNA. GFP-expressing embryos were
screened for primary cell culture preparation. For both GFP-
expressing and wild-type non-injected embryos, muscle cells were
dissociated from the myotomal tissues of the 1-d-old embryos
at Nieuwkoop and Faber stage 19–22 (Nieuwkoop and Faber, 1994)
after collagenase treatment, and were plated on glass coverslips
coated with a mixture of cell attachment substrates, entactin–
collagen IV-laminin (Millipore). The muscle cell cultures were
grown in culture medium containing 10% Leibovitz's L-15 medium
(vol/vol; Sigma), 87% Steinberg's solution (vol/vol; 60 mM NaCl,
0.67 mM KCl, 0.35 mM Ca(NO3)2, 0.83 mM MgSO4, 10 mM
HEPES, pH 7.4), 1% fetal bovine serum (vol/vol), 1% penicillin/
streptomycin (vol/vol) and 1% gentamicin sulfate (vol/vol), and
were kept in room temperature at 23 1C for at least 1 d before
experiments begin to enhance cell attachment and to develop
aneural AChR clusters. To make nerve–muscle co-cultures, we
plated dissociated spinal neurons on 1-d-old muscle cultures to
induce neuromuscular synaptogenesis, and then observed the
nerve-induced AChR clusters after 2 d in co-culture. All of the
experiments involving Xenopus frogs and embryos were carried
out in accordance with the approved protocol by the Institutional
Animal Care and Use Committee (IACUC) of the National Univer-
sity of Singapore.
Live labeling of acetylcholine receptors and cell ﬁxation
The localization of AChR clusters was labeled with 1 mg/ml
rhodamine-conjugated α-bungarotoxin (Rh-BTX, Life Technolo-
gies) for 45 min in live muscle cells or nerve–muscle co-cultures,
then the cultures were washed extensively with culture medium
for at least 3 times. To observe live cells at high magniﬁcation with
oil immersion objectives, glass coverslips with cultured cells were
mounted on custom-made sealed chambers containing culture
medium with or without MG patient plasma. In some experi-
ments, Xenopus muscle cells were ﬁxed at speciﬁc time-points
with 20 1C cold ethanol for 3 min or 4% paraformaldehyde for
15 min, then the cultures were washed extensively with phos-
phate buffered saline (PBS) for at least 3 times. The coverslips were
then mounted on glass slides with an anti-bleaching agent
Fluoromount-G (Southern Biotech) for later examination.
Microscopy and data analysis
All wide-ﬁeld ﬂuorescence imaging on live and ﬁxed cell
cultures was performed on inverted ﬂuorescence microscopes,
IX83 (Olympus) or TE2000U (Nikon). Digital images were acquired
by an ORCA D2 CCD camera (Hamamatsu) through the use of an
open source microscopy software Micro-Manager (Edelstein et al.,
2010) or by a CoolSNAP ES CCD camera (Photometrics) through the
use of MetaMorph imaging software (Molecular Devices). All
images were taken with identical settings between the control
and experimental groups. The aneural and nerve-induced AChR
clusters were quantiﬁed by scoring the presence or absence of
AChR clusters in cultured muscle cells. The presence of nerve-
induced AChR clusters was quantiﬁed by ﬁrst identifying nerve–
muscle contacts in phase-contrast and then calculating the per-
centages of nerve–muscle contact sites with AChR aggregates.
Data were shown as mean7SEM and the statistical signiﬁcance of
differences between the control and experimental groups was
assessed by Student's t-test.
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Results and discussion
MG patient plasma induces the disassembly of spontaneously formed
aneural AChR clusters
The current CBA for MG involves the use of heterologous cell
lines exogenously expressed with target synaptic membrane
proteins that may not react with the presence of possible auto-
antibodies against densely clustered AChRs in the physiological
condition (Devic et al., 2014; Jacob et al., 2012). To improve the
CBA for screening the pathogenicity of autoantibodies in MG
patient plasma samples, we employed the well-established Xeno-
pus primary culture system that allows the multifaceted investiga-
tion of NMJ formation and maintenance in vitro (Peng et al., 1991).
In this study, we have systematically evaluated the pathogenicity
of four MG patient plasma samples, which were obtained from
two SPMG patients (anti-AChR-positive) and two SNMG patients
(anti-AChR-negative) by plasma exchange, on the disassembly of
aneural and synaptic AChR clusters in cultured Xenopus muscle or
nerve–muscle co-cultures, respectively. The detailed clinical char-
acteristics of the MG patients were shown in Table 1.
We ﬁrst examined the effects of MG patient plasma samples on
the aneural AChR clusters in 3-d-old cultured Xenopus muscle
cells. AChR molecules were labeled with a low concentration of
Rh-BTX, which binds to the α1 subunit of AChR molecules
(Gershoni et al., 1983). Consistent with our previous study (Lee
et al., 2009), we observed one complex structure of aneural AChR
clusters in the whole muscle cell that was spontaneously formed
in the surface membrane when the muscle cells were cultured on
the laminin-containing substrate (Fig. 1A, inset in control). These
aneural AChR clusters share several characteristics with the
mature postsynaptic apparatus in vivo, including the presence of
multiple postsynaptic markers, and the transformation of cluster
morphology during development (Kummer et al., 2004). Here, we
treated the cultured Xenopus muscle cells with either SPMG or
SNMG plasma samples for 4 h, followed by cell ﬁxation for
imaging and quantitative analysis. We found that all 4 MG plasma
samples, regardless of SPMG or SNMG, effectively induced the
disassembly of aneural AChR clusters in cultured muscle cells,
while we did not observe any noticeable change in the clusters
upon the treatment of cultured muscle cells with normal human
serum (NHS) (Fig. 1A). Quantitative analysis on over 250 muscle
cells from 5 independent experiments further supported that both
Table 1
Clinical characteristics of MG human patients.
Patient No. Sex Diagnosis Age of sampling Age of onset Therapy
1 F AChR þ 61 61 PSL, THY, PE
2 F AChR þ 31 11 PSL, THY, PE
3 F AChR  35 35 PSL, PE
4 M AChR  81 80 PSL, PE
AChR þ: Positive to anti-AChR autoantibodies; AChR : Negative to anti-AChR
autoantibodies; PSL: Prednisolone; THY: Thymectomy; PE: Plasma exchange.
Fig. 1. Pathogenic effects of human MG patient plasma on the disassembly of aneural AChR clusters. (A) Representative images showing the effects of 4 different plasma
samples from SPMG or SNMG patients on the maintenance of aneural AChR clusters in cultured Xenopus muscle cells. Normal human serum, NHS, was used as a negative
control. The presence of aneural AChRs was observed in control and NHS-treated muscle cells, but not in the cells after a 4-h treatment of either SPMG or SNMG plasma
samples. The periphery of muscle cells was identiﬁed in the phase contrast images and was outlined with white dotted lines in the ﬂuorescence images for clarity. Insets
showed the magniﬁed view (3 ) of the aneural AChR clusters in control and NHS-treated cells. Asterisks represent the non-speciﬁc auto-ﬂuorescence signals caused by yolk
granules inside the cells. (B) Quantiﬁcation showing the percentage of cultured muscle cells with AChR clusters in response to human MG patient plasma. The presence of
aneural AChR clusters in cultured muscle cells was scored after the 4-h treatment of SPMG or SNMG patient plasma. The respective percentage values were normalized with
the untreated control. Data are represented as mean7SEM. npo0.05, nnpo0.01, t test. N¼250 muscle cells from 5 independent experiments in each condition.
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SPMG and SNMG patient plasma samples were equally pathogenic
in inducing the disassembly of aneural AChR clusters in cultured
Xenopus muscle cells (Fig. 1B). For the two SPMG patient plasma,
the percentages of muscle cells with AChR clusters were signiﬁ-
cantly reduced to 38% (patient 1) or 36% (patient 2), compared
to the untreated control. Likewise, the two SNMG patient plasma
samples also showed a signiﬁcant reduction in the percentage of
muscle cells with AChR clusters to 39% (patient 3) or 19%
(patient 4). In contrast, NHS only slightly, and not signiﬁcantly,
affected AChR clustering (Fig. 1B).
Since AChR molecules were labeled with Rh-BTX that binds to
their α1 subunit (Gershoni et al., 1983), this may potentially
interfere with the binding of autoantibodies to the Rh-BTX-
labeled AChRs leading to a false negative result. However, all MG
plasma samples tested in this study effectively induced the
disassembly of Rh-BTX-labeled AChR clusters, suggesting that the
Rh-BTX-binding site of AChR molecules was not at the antigen of
autoantibodies in these samples. To avoid the potential false
negative results, AChR labeling with Rh-BTX in cultured muscle
cells could be performed after the treatment with patient plasma
samples. If the pathogenic autoantibodies and Rh-BTX bind to the
same site of AChR molecules, the plasma treatment would block
the subsequent Rh-BTX labeling and result in a large reduction of
AChR signals in cultured muscle cells.
Next, we performed time-lapse imaging to investigate the
dynamic changes in the morphology and density of aneural AChR
clusters in cultured Xenopus muscles upon MG plasma treatment.
Speciﬁcally, we ﬁrst labeled all surface AChRs in cultured muscle
cells with Rh-BTX at 0 h, then the same AChR clusters were
followed up to 40 h in the presence or absence of the SPMG
plasma. In the control muscle cells, AChR clusters appeared to be
relatively stable as we did not detect a drastic change in terms of
the size and intensity of the ﬂuorescence signals from Rh-BTX-
labeled AChRs (Fig. 2A), suggesting the slow turnover rate of
surface AChRs and the minimal photo-bleaching effects during
Fig. 2. Time-lapse imaging on the disassembly of aneural AChR clusters induced by
MG patient plasma. (A) and (B) A series of time-lapse ﬂuorescence images showing
the effects of the SPMG patient plasma on the maintenance of AChR clusters in
cultured Xenopusmuscle cells. The same AChR clusters were followed over a period
of 40 h in the absence (A) or presence (B) of the SPMG patient plasma. To clearly
depict the change in ﬂuorescence intensity of AChR, 8-bit pseudo-colored images
were showed in the bottom panels for each condition.
Fig. 3. Pathogenic effects of human MG patient plasma on the disassembly of nerve-induced AChR clusters. (A) Representative images showing the effects of 4 different plasma
samples from SPMG or SNMG patients on the maintenance of synaptic AChR clusters in Xenopus nerve–muscle co-cultures. NHS was used as a negative control. The presence of
synaptic AChR clusters (arrows) was detected by Rh-BTX labeling at nerve–muscle contacts in control and NHS-treated co-cultures, but not in the co-cultures after a 4-h treatment of
either SPMG or SNMG plasma samples (arrowheads). Asterisks represent the non-speciﬁc auto-ﬂuorescence signals caused by yolk granules inside the cells. (B) Quantiﬁcation showing
the percentage of nerve–muscle contacts with AChR clusters in response to humanMG patient plasma. The presence of synaptic AChR clusters in cultured muscle cells was scored after
the 4-h treatment of SPMG or SNMG patient plasma. The respective percentage values were normalized with the untreated control. Data are represented as mean7SEM. npo0.05,
nnpo0.01, t test. N¼142 (control), 30 (patient 1), 42 (patient 2), 74 (patient 3), 32 (patient 4), and 53 (NHS) from 6 independent experiments.
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the entire imaging period. In contrast, the size and intensity of
AChR clusters were gradually reduced in cultured muscle cells
treated with the SPMG plasma (Fig. 2B). In this example, the
aneural AChR cluster had largely disappeared at 40-h time point
after the plasma treatment. Similar results were obtained when
cultured Xenopusmuscle cells were treated with the SNMG patient
plasma samples (data not shown). These data suggested that
cultured Xenopus muscle cells endogenously express all the post-
synaptic proteins required for the formation of the stable aneural
AChR clusters in the muscle membrane; and both SPMG and
SNMG patient plasma may contain autoantibodies against AChR
molecules or other postsynaptic membrane proteins that de-
stabilize the aneural AChR clusters leading to their disassembly.
MG patient plasma induces the disassembly of nerve-induced
synaptic AChR clusters
Regardless of the striking similarity between aneural and
synaptic AChR clusters, the differences in their associated cytos-
keletal scaffolds may result in the differential turnover rate and
stability of these two pools of surface AChRs (Gervasio et al., 2007;
Sadasivam et al., 2005). In addition, a previous study suggested
that autoantibodies from MG patient plasma show a higher
immunochemical properties against extra-synaptic than synaptic
AChR clusters (Dwyer et al., 1981). Therefore, an experimental
setup involving co-cultures of Xenopus spinal neurons and muscle
cells was also used to investigate the pathogenic effects of SPMG
and SNMG patient plasma on the synaptic AChR clusters induced
by spinal motor neurons. In this experiment, we prepared the
Xenopus nerve–muscle co-cultures by plating the dissociated
neural tube tissues in 1-d-old cultured Xenopus muscle cells.
When the spinal neuron comes into contact with the muscle cell,
synaptogenesis follows (Dai and Peng, 1996), as evidenced by the
clustering of AChR at the nerve–muscle contact sites (Fig. 3A,
arrows in control). However, we detected a large reduction in the
numbers of nerve-induced AChR clusters in the 2-d-old Xenopus
nerve–muscle co-cultures treated with either SPMG or SNMG
plasma for 4 h (Fig. 3A, arrowheads). Quantiﬁcation from a pool
of muscle cells with spinal neuron contacts showed that both
SPMG and SNMG plasma samples effectively induced the disas-
sembly of nerve-induced synaptic AChR clusters in cultured
Xenopus nerve–muscle co-cultures, while NHS treatment did not
signiﬁcantly affect the nerve-induced AChR clustering (Fig. 3B).
Speciﬁcally, the numbers of nerve–muscle contacts with AChR
clusters were reduced to 66% (patient 1) or 52% (patient 2),
compared to the untreated control nerve–muscle co-cultures.
Likewise, two SNMG patient plasma also showed a large reduction
in the numbers of nerve-induced AChR clusters at the contact sites
to 52% (patient 3) or 44% (patient 4). It is of interest to note
that the synaptic AChR clusters were less susceptible to their
disassembly than the aneural AChR clusters in response to the
treatment with the same patient plasma sample (Figs. 1B and 3B).
This could be contributed by the differences in the cytoskeletal
scaffolds associated to the synaptic versus aneural AChR clusters
(Bloch et al., 1989; Campanelli et al., 1994). In addition, nerve-
secreted agrin and growth factors may also increase the metabolic
stability of synaptic AChR clusters (Dai and Peng, 1992; Phillips
et al., 1997), thus dampening the pathogenic effects of the patient
plasma on synaptic AChR clusters. Our future study will examine
the nerve-secreted factors and the differences in cytoskeletal
scaffolding proteins underneath those nerve-induced AChR clus-
ters that are more resistant towards the MG plasma treatment.
Among all the SPMG and SNMG patient plasma samples tested
in this study, the plasma sample from patient 4 was identiﬁed to
be the most pathogenic in inducing the disassembly of aneural
and synaptic AChR clusters in Xenopus muscle and nerve–muscle
co-cultures, respectively (Figs. 1B and 3B). Since anti-AChR auto-
antibodies were not present in this SNMG patient plasma, the
identiﬁcation of any possible novel antigen(s), which showed a
higher pathogenicity than anti-AChR autoantibodies, remains to
be investigated. A recent study showed that autoantibodies against
MuSK can cause tyrosine phosphorylation of MuSK and AChR β-
subunit, thus accelerating MuSK internalization from the plasma
membrane (Cole et al., 2010). This suggested that some autoanti-
bodies in MG patients may impair NMJs by inﬂuencing the post-
translational modiﬁcation and stability of postsynaptic proteins.
Therefore, in addition to the antigenic modulation pathway of the
crosslinking-induced endocytosis and degradation of postsynaptic
proteins, some SNMG patient plasma samples may cause a more
severe disruption of AChR clusters than the SPMG samples.
Similar to the aneural AChR clusters, we also performed time-
lapse imaging to investigate the dynamic changes in the nerve-
induced AChR clusters upon the treatment of MG plasma samples
(Fig. 4). In the control nerve–muscle co-culture, the nerve-induced
AChR clusters were quite stable throughout the entire imaging
period of 48 h (Fig. 4A, arrows). However, in the co-culture treated
with the SPMG plasma sample, we observed a gradual disassembly
of AChR clusters at the nerve–muscle contacts (Fig. 4B). In this
example, we identiﬁed 3 nerve-induced AChR clusters at the
nerve–muscle contact sites before the plasma treatment (Fig. 4B,
arrows at 0 h). At 20 h after the treatment, 2 nerve-induced AChR
clusters completely disappeared (Fig. 4B, arrowheads at 20 h),
Fig. 4. Time-lapse imaging on the disassembly of nerve-induced AChR clusters by
MG patient plasma. (A) and (B) Representative sets of time-lapse images showing
the effects of the SPMG patient plasma on the maintenance of synaptic AChR
clusters in Xenopus nerve–muscle co-cultures. The same AChR clusters at nerve–
muscle contacts were followed over a period of 48 h in the absence (A) or presence
(B) of the SPMG plasma. The nerve-induced synaptic AChR clusters remained stable
throughout the entire imaging period in the control co-culture (A, arrows), while a
gradual disappearance of the nerve-induced AChR clusters was observed in the
SPMG plasma-treated co-culture (B, arrows changed to arrowheads). To better
depict the change in ﬂuorescence intensity of AChR clusters, 8-bit pseudo-colored
images were shown in the bottom panels for each condition.
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while the size and intensity of the remaining nerve-induced AChR
clusters also drastically reduced over the next 28 h (Fig. 4B, arrows
in 48 h). Likewise, treatment of Xenopus nerve–muscle co-cultures
with the SNMG plasma sample also resulted in a gradual disas-
sembly of the nerve-induced AChR clusters (data not shown).
These data suggested that the MG patient plasma contains auto-
antibodies against AChR or other postsynaptic proteins that cause
a gradual disassembly of synaptic AChR clusters at the NMJs.
Correlation between ADF/coﬁlin localization and AChR cluster
disassembly
Our recent study showed that a family of an actin-binding
protein, ADF/coﬁlin, regulates the dynamic actin turnover for the
surface targeting of AChRs via vesicular trafﬁcking at developing
NMJs (Lee et al., 2009). We hypothesized that a similar cytoskeletal
regulation mediated by ADF/coﬁlin is involved in the induction of
AChR endocytosis leading to the disassembly of AChR clusters
during MG pathogenesis. To test this hypothesis, we further
examined the dynamic localization of ADF/coﬁlin in live muscle
cells and its correlation to the disassembly of AChR clusters
induced by the SPMG patient plasma. To examine the spatial and
temporal correlation between ADF/coﬁlin localization and AChR
cluster disassembly upon the SPMG patient plasma treatment, we
performed dual-channel live-cell imaging on muscle cultures
expressing fusion proteins of XAC and GFP in conjunction with
Rh-BTX labeling (Fig. 5). We found that GFP–XAC was highly
enriched at the aneural AChR clusters in cultured muscle cells at
the beginning of this time-lapse series (Fig. 5A, 0 h). Consistent
with our data in Figs. 1 and 2, treatment of cultured Xenopus
muscle cells with the SPMG patient plasma sample effectively
induced the disassembly of the aneural AChR clusters (Fig. 5A, top
row). Intriguingly, we also observed the progressive reduction of
GFP–XAC puncta within the aneural clusters (Fig. 5A, middle row),
that was spatially correlated to the disassembly of AChR clusters.
Quantiﬁcation showed that the disappearance of GFP–XAC was
tightly coupled temporally to the AChR cluster disassembly
induced by the SPMG plasma sample treatment (Fig. 5B). These
data implicated the requirement of ADF/coﬁlin for the mainte-
nance of AChR clusters, and the pathogenic plasma from the MG
patient may actively or passively disrupt the localization of ADF/
coﬁlin for the maintenance of aneural or synaptic AChR clusters.
Fig. 5. Spatio-temporal correlation between AChR cluster disassembly and ADF/coﬁlin localization. (A) A representative series of time-lapse images showing the correlation
between the disassembly of aneural AChR clusters and ADF/coﬁlin localization induced by the SPMG plasma treatment in Xenopus muscle cultures. To clearly depict the
change in ﬂuorescence intensity of AChR and GFP–XAC, 8-bit pseudo-colored images were showed in the bottom panels for each marker. The spatial correlation between
AChR (red) and GFP–XAC (green) was shown in the merged color images in the bottom row. (B) Quantitative analysis showing the temporal change in the integrated
intensity of AChR and GFP–XAC ﬂuorescence signals in response to the SPMG plasma treatment. The respective intensities were normalized with their integrated intensity
values at 0 h. N¼3. Data are represented as mean7SEM.
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Furthermore, our previous study showed that overexpression of
GFP–XAC phosphorylation mutants in Xenopus muscle cultures
reduces the number and size of synaptic AChR clusters induced by
nerve innervation (Lee et al., 2009), suggesting that the activity of
ADF/coﬁlin is required for the maintenance of synaptic AChR
clusters. However, the exact function of ADF/coﬁlin in the regula-
tion of AChR cluster disassembly warrants further investigation in
the future.
Previous studies have indicated the essential role of the
dynamic remodeling of actin cytoskeleton during both endocytosis
and exocytosis (Engqvist-Goldstein and Drubin, 2003; Lanzetti,
2007; Schafer, 2002). Based on our recent studies showing the
requirement of ADF/coﬁlin for surface delivery of AChR to the
postsynaptic membrane by exocytosis (Lee et al., 2009), the
present study showed that ADF/coﬁlin may also be involved in
the autoantibody-mediated endocytosis leading to the disassem-
bly of AChR clusters during the pathogenesis of MG. ADF/coﬁlin,
through its severing activity, could generate new actin barbed
ends and monomeric G-actin, which in turn could enhance the
turnover rate of actin ﬁlaments to facilitate endocytosis (Bamburg,
1999; Sarmiere and Bamburg, 2004). Further studies on the
regulation of ADF/coﬁlin activity by its upstream regulators will
provide additional evidences showing the spatiotemporal regula-
tion of actin dynamics by localized ADF/coﬁlin at sites of the
autoantibody-mediated AChR endocytosis in MG pathogenesis.
In summary, considering the potential pitfalls of the current
cell-based diagnostic assays as described above, it is essential to
develop reliable, sensitive and speciﬁc tools that help to diagnose
MG, even at the early stage of pathogenesis. Despite the fact that
most CBAs are relatively labor intensive, the use of cultured
Xenopus tissue cultures would still serve as a reliable, alternative
CBA to screen the pathogenicity of MG human patient samples for
the disassembly of AChR clusters in vitro. The assay described in
this study may be employed to distinguish the disease severity
among different patients, to monitor the course of the disease and
the efﬁcacy of treatment received for a particular MG patient, and
to study the pathogenic mechanisms underlying the
autoantibody-induced AChR endocytosis and degradation during
MG pathogenesis.
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